SALVESTRINI, VIOLA
 Distribuzione geografica
Continente #
AS - Asia 2.854
NA - Nord America 2.798
EU - Europa 1.815
SA - Sud America 256
AF - Africa 63
OC - Oceania 36
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.825
Nazione #
US - Stati Uniti d'America 2.741
CN - Cina 910
RU - Federazione Russa 899
SG - Singapore 833
HK - Hong Kong 332
KR - Corea 279
IT - Italia 250
BR - Brasile 199
VN - Vietnam 167
IE - Irlanda 128
FR - Francia 125
DE - Germania 97
IN - India 87
FI - Finlandia 74
SE - Svezia 74
GB - Regno Unito 52
ID - Indonesia 47
JO - Giordania 44
BD - Bangladesh 43
PL - Polonia 38
AU - Australia 35
AR - Argentina 28
CA - Canada 27
JP - Giappone 19
MX - Messico 18
IQ - Iraq 16
NL - Olanda 16
NG - Nigeria 12
TR - Turchia 12
PK - Pakistan 11
MA - Marocco 10
EC - Ecuador 9
ES - Italia 9
ZA - Sudafrica 8
BE - Belgio 7
UA - Ucraina 7
VE - Venezuela 7
BJ - Benin 6
EG - Egitto 6
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
GR - Grecia 5
SA - Arabia Saudita 5
TN - Tunisia 5
AT - Austria 4
AZ - Azerbaigian 4
BY - Bielorussia 4
CO - Colombia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
PH - Filippine 4
PT - Portogallo 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
CL - Cile 3
DK - Danimarca 3
LB - Libano 3
PE - Perù 3
AQ - Antartide 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
EE - Estonia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TM - Turkmenistan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.825
Città #
Santa Clara 828
Singapore 644
Ashburn 455
Hefei 358
Hong Kong 301
Seoul 279
San Jose 192
Chandler 142
Dublin 128
Los Angeles 81
Beijing 74
Munich 69
Ho Chi Minh City 63
Moscow 57
New York 54
Kent 51
Paris 47
Lauterbourg 44
Fairfield 43
Buffalo 42
Florence 41
Helsinki 37
Council Bluffs 36
Ann Arbor 33
Melbourne 32
Warsaw 32
The Dalles 30
Hanoi 29
Mumbai 29
Shanghai 29
Seattle 28
Bengaluru 26
Jakarta 26
São Paulo 25
Altamura 24
Lawrence 24
Dallas 20
London 19
Turku 19
Woodbridge 19
Boston 17
Houston 17
Lappeenranta 17
Milan 17
Cambridge 15
Tokyo 15
Wilmington 15
Frankfurt am Main 14
Princeton 13
Orem 11
West Jordan 11
Abuja 10
Naples 10
Chennai 9
Pune 9
Baghdad 8
Belo Horizonte 8
Buenos Aires 8
Chicago 8
Denver 8
Rome 8
Shenzhen 8
Stockholm 8
Toronto 8
Brussels 7
Guangzhou 7
Bologna 6
Brooklyn 6
Cotonou 6
Da Nang 6
Karachi 6
Malang 6
Medford 6
Mexico City 6
Phoenix 6
Yubileyny 6
Zhengzhou 6
Abidjan 5
Johannesburg 5
Manchester 5
Porto Alegre 5
Quito 5
San Diego 5
Amman 4
Atlanta 4
Baku 4
Biên Hòa 4
Boardman 4
Campinas 4
Charlotte 4
Lucca 4
Nanjing 4
Ninh Bình 4
Qingdao 4
Redondo Beach 4
Ribeirão Preto 4
Rosora 4
Tashkent 4
Vienna 4
Wroclaw 4
Totale 4.960
Nome #
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 234
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 199
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 192
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 187
Artificial Intelligence in radiotherapy: state of the art and future directions 180
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 176
A critical review on oligometastatic disease: a radiation oncologist’s perspective 174
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 174
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 173
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 171
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 170
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 168
Thermal Ablation versus SBRT in liver tumours: pros and cons 167
Open-Face Masks in Radiotherapy: Enhancing Therapeutic Strategies for Head and Neck and Brain Cancer Patients—A Comprehensive Scoping Review 166
Impact of COVID-19 on workload burden of a complex radiotherapy facility 166
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 165
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 164
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 164
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 161
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 160
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 159
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 158
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 156
Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis 155
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 153
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 153
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 150
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 148
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 148
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 146
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 144
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 140
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 137
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 134
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 133
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 128
The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique 124
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 124
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement 122
Recent advances in de-intensification of radiotherapy in elderly cancer patients 118
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 118
The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 114
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 112
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 112
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 111
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery 110
Progress and Challenges in Integrating Nutritional Care into Oncology Practice: Results from a National Survey on Behalf of the NutriOnc Research Group 102
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures 96
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 91
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 90
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 85
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 79
The impact of modern radiotherapy on radiation-induced late sequelae: Focus on early-stage mediastinal classical Hodgkin Lymphoma. A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 75
Quitting smoking after head and neck squamous cell carcinoma diagnosis: a prospective study protocol 35
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review 29
Upgrading your best chances: postdiagnosis smoking cessation boosts life expectancy of patients with cancer – a systematic review and meta-analysis 17
Totale 7.881
Categoria #
all - tutte 25.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 4 6
2021/2022113 4 0 4 12 6 2 10 13 7 7 20 28
2022/2023542 24 84 25 20 52 120 67 45 82 3 15 5
2023/2024444 16 30 36 24 22 62 23 107 21 41 46 16
2024/20252.877 73 254 119 392 726 407 70 159 149 98 159 271
2025/20263.750 453 587 591 296 427 129 470 179 219 247 152 0
Totale 7.881